Chondroxide ointment 30g №1

Name:
Chondroxide ointment tubes 30g in pack №1
Description:
Light yellow ointment with the smell of dimethyl sulfoxide. The main active ingredient Chondroitin sulfate Release form Ointment Pharmacological action Pharmacodynamics Chondroitin sulfate is a mucopolysaccharide and one of the components of cartilage. It has a high ability to bind water, thus it provides the mechanical and elastic properties of the cartilage. With degenerative processes in the joints, a decrease in the reserves of chondroitin sulfate in cartilage tissue is observed, caused by specific lytic enzymes. As a result of the deterioration of the ability to bind water, damage to the articular cartilage and dysfunction of the joints progresses. Chondroitin sulfate inhibits cartilage-degrading elastase in vitro. Dimethyl sulfoxide, which is part of the ointment, has anti-inflammatory, analgesic and fibrinolytic effects, promotes better penetration of the active substance (chondroitin sulfate) through cell membranes. Indications for use Local relief of symptoms of pain and inflammation in osteoarthritis of the superficial joints and osteochondrosis of the spine. Method of administration and doses The ointment is applied externally, applied 2-3 times a day to the area of the affected joint at the rate of 1-2 g per 100-200 cm2 of skin and gently rubbed until completely absorbed within 2-3 minutes. A column of ointment of 1 cm, squeezed out of a tube, corresponds to 0.3 g. The course of treatment is 2-3 weeks. If necessary, the course of treatment is repeated. Data on the efficacy and safety of the use of Chondroxide in children are currently not available. Use during pregnancy and lactation Use of the drug during pregnancy and lactation is contraindicated. Influence on the ability to drive vehicles and other potentially dangerous mechanisms Does not affect. Precautions Apply to intact skin. Avoid getting the ointment in the eyes, mucous membranes and open wounds. Information about excipients. The medicinal product contains lanolin, which may cause local skin reactions (eg contact dermatitis). Interaction with other drugs No cases of negative drug interaction have been established when prescribing Chondroxide ointment with other drugs included in conventional treatment regimens for degenerative diseases of the joints and spine. Contraindications Hypersensitivity, tendency to bleeding, thrombophlebitis, damage to the skin, children’s age (the effectiveness and safety of the drug has not been established), pregnancy, lactation (it is necessary to stop breastfeeding for the period of treatment). One tube is composed of: active substances: sodium chondroitin sulfate – 1.5 g, dimethyl sulfoxide – 3.0 g; excipients: lanolin, soft white paraffin, purified water. Overdose The phenomena of overdose when using the drug are not described. Side effectsThe frequency of side effects is given in the following gradation: very often (? 1 / 10), often (? 1/100, < 1/10), less often (? 1/1000, < 1/100), rarely (? 1 / 10000, < 1/1000), very rare (< 1/10000); unknown (according to the available data, it is not possible to determine the frequency of occurrence). Rarely: allergic reactions, hyperemia, itching. If allergic reactions occur, treatment with the drug should be discontinued, in case of severe redness and itching, desensitizing therapy should be carried out. If the listed adverse reactions occur, as well as a reaction not mentioned in the instructions, you should consult a doctor. Storage conditionsStore at a temperature not exceeding 25°C. Keep out of the reach of children. Buy Chondroxide ointment 30g №1